Letter: Dermatitis herpetiformis, iodine compounds and thyrotoxicosis.
D000328:Adult; D000368:Aged; D002231:Carbimazole / Q000008:administration & dosage / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000139:chemically induced* / Q000178:diet therapy / Q000188:drug therapy; D005260:Female; D005983:Glutens / Q000009:adverse effects; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007455:Iodine / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D013427:Sulfapyridine / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use
D005983:Glutens; D002231:Carbimazole; D003622:Dapsone; D007455:Iodine; D013974:Thyroxine; D013427:Sulfapyridine